Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.
Ranganayaki MuralidharanAnish BabuNarsireddy AmreddyKanthesh BasalingappaMeghna MehtaAllshine ChenYan Daniel ZhaoUday B KompellaAnupama MunshiRajagopal RameshPublished in: Journal of nanobiotechnology (2016)
Our results demonstrate that HuR is a molecular target for lung cancer therapy and its suppression using HuR-FNP produced significant therapeutic efficacy in vitro.